Life-science tool stocks thrive away from Obamacare glare

NEW YORK (Reuters) - Away from the political spotlight on Obamacare and high medicine prices, a section of the U.S. healthcare industry is quietly thriving on the stock market.

Life-science tool stocks thrive away from Obamacare glare
Read More


Bagikan Berita Ini